Results 101 to 110 of about 3,893,535 (160)

Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors. [PDF]

Cancers (Basel)
Iizuka T, Kobayashi N, Wild D, Kaul F, Suzuki H, Maehara K, Okubo N, Tsuyuki S, Takano S, Kurita Y, Yoneda M, Ichikawa Y.   +11 more
europepmc   +1 more source

Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients. [PDF]

Curr Treat Options Oncol
Mohindroo C, Ramirez RA.
europepmc   +1 more source

Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions. [PDF]

Eur J Nucl Med Mol Imaging
Virgolini IJ, Di Santo G, Santo G.
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy-Induced Hypercortisolemic Crisis in Ectopic Cushing Syndrome. [PDF]

JCEM Case Rep
Pandit R, Yamichannaiah C, Lila AR, Karlekar M, Memon SS, Bandgar T.   +5 more
europepmc   +1 more source

Direct estimation of activity concentration in regional voxels with application to ¹⁷⁷Lu peptide receptor radionuclide therapy. [PDF]

Med Phys
Gustafsson J, Larsson E, Sjögreen Gleisner K.   +2 more
europepmc   +1 more source

Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis. [PDF]

Thyroid Res
Abdlkadir AS, Al-Adhami D, Shi H, Sathekge MM, Sheikha AA, Mohamad I, Kreissl M, Al-Ibraheem A.   +7 more
europepmc   +1 more source

¹⁷⁷Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumors: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Wang J, Pang X, Lian J, Lu H.
europepmc   +1 more source

Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. [PDF]

AACE Endocrinol Diabetes
Yu R, Gardner L, Salavati A, Bahri S.
europepmc   +1 more source

Somatostatin receptor expression for peptide receptor radionuclide therapy in Japanese patients with recurrent or metastatic differentiated thyroid cancer. [PDF]

Ann Nucl Med
Watanabe S, Hirata K, Takenaka J, Munakata Y, Magota K, Wakabayashi N, Koga H, Kudo K.   +7 more
europepmc   +1 more source

Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing ¹⁷⁷Lu-Based Peptide Receptor Radionuclide Therapy. [PDF]

Cancers (Basel)
Baur S, Ruhwedel T, Böke E, Kobus Z, Lishkova G, Wetz C, Amthauer H, Roderburg C, Tacke F, Rogasch JM, Samek W, Jann H, Ma J, Eschrich J.   +13 more
europepmc   +1 more source